Skip to main content

Table 3 Late treatment-related complications

From: Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma

Complications ENPG (N = 10) IMRT (N = 220) P*
n % n %
Auditory/hearing 0.069
 0 10 100 138 62.7  
 1–2 0 0 63 28.7  
 3–4 0 0 19 8.6  
Trismus 0.369
 0 10 100 184 83.6  
 1–2 0 0 36 16.4  
 3–4 0 0 0 0  
Dysphagia 0.674
 0 10 100 190 86.4  
 1–2 0 0 26 11.8  
 3–4 0 0 4 1.8  
Skin      1.000
 0 9 90.0 193 87.7  
 1–2 1 10.0 25 11.4  
 3–4 0 0 2 0.9  
Subcutaneous soft tissue 0.611
 0 10 100 193 87.7  
 1–2 0 0 27 12.3  
 3–4 0 0 0 0  
Dry mouth < 0.001
 0 9 90.0 52 23.6  
 1–2 1 10.0 119 54.1  
 3–4 0 0 49 22.3  
Cranial neuropathy 0.473
 0 10 100 207 94.1  
 1–2 0 0 13 5.9  
 3–4 0 0 0 0  
Peripheral neuropathy 1.000
 0 10 100 218 99.1  
 1–2 0 0 2 0.9  
 3–4 0 0 0 0  
Endocrine dysfunction 1.000
 0 10 100 211 95.9  
 1–2 0 0 9 4.1  
 3–4 0 0 0 0  
Temporal lobe necrosis 1.000
 0 10 100 205 93.2  
 1–2 0 0 15 6.8  
 3–4 0 0 0 0  
  1. ENPG endoscopic nasopharyngectomy, IMRT intensity-modulated radiotherapy
  2. * Fisher’s exact test